Management of Patients With Crohn's Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting.
作者： David T. Rubin , Maria T. Abreu , Victoria Rai , Corey A. Siegel , Vineet Ahuja
DOI: 10.1053/J.GASTRO.2020.04.002
关键词: Pneumonia 、 Betacoronavirus 、 Medicine 、 Crohn's disease 、 Pandemic 、 Colitis 、 Immunotherapy 、 Disease management (health) 、 Internal medicine 、 Ulcerative colitis
摘要: … IBD and the absence of data, members of the organization recognized the need for rapid international collaboration and held 2 IBD… of patients with IBD during this pandemic. Using …
gastrojournal.org
narcis.nl参考文章(24)
Iris Dotan, Lael Werner, Sharon Vigodman, Shradha Agarwal, Jorge Pfeffer, Noya Horowitz, Lisa Malter, Maria Abreu, Thomas Ullman, Hanan Guzner-Gur, Zamir Halpern, Lloyd Mayer, Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines. Inflammatory Bowel Diseases. ,vol. 18, pp. 261- 268 ,(2012) , 10.1002/IBD.21688
Chris Ka-fai Li, Hao Wu, Huiping Yan, Shiwu Ma, Lili Wang, Mingxia Zhang, Xiaoping Tang, Nigel J. Temperton, Robin A. Weiss, Jason M. Brenchley, Daniel C. Douek, Juthathip Mongkolsapaya, Bac-Hai Tran, Chen-lung Steve Lin, Gavin R. Screaton, Jin-lin Hou, Andrew J. McMichael, Xiao-Ning Xu, T Cell Responses to Whole SARS Coronavirus in Humans Journal of Immunology. ,vol. 181, pp. 5490- 5500 ,(2008) , 10.4049/JIMMUNOL.181.8.5490
Manisha Lamba, Rong Wang, Tracey Fletcher, Christine Alvey, Joseph Kushner, Thomas C. Stock, Extended-Release Once-Daily Formulation of Tofacitinib: Evaluation of Pharmacokinetics Compared With Immediate-Release Tofacitinib and Impact of Food. The Journal of Clinical Pharmacology. ,vol. 56, pp. 1362- 1371 ,(2016) , 10.1002/JCPH.734
S. N. Byrareddy, J. Arthos, C. Cicala, F. Villinger, K. T. Ortiz, D. Little, N. Sidell, M. A. Kane, J. Yu, J. W. Jones, P. J. Santangelo, C. Zurla, L. R. McKinnon, K. B. Arnold, C. E. Woody, L. Walter, C. Roos, A. Noll, D. Van Ryk, K. Jelicic, R. Cimbro, S. Gumber, M. D. Reid, V. Adsay, P. K. Amancha, A. E. Mayne, T. G. Parslow, A. S. Fauci, A. A. Ansari, Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy Science. ,vol. 354, pp. 197- 202 ,(2016) , 10.1126/SCIENCE.AAG1276
Rudragouda Channappanavar, Stanley Perlman, Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology Seminars in Immunopathology. ,vol. 39, pp. 529- 539 ,(2017) , 10.1007/S00281-017-0629-X
Kent J. Weinhold, Jack F. Bukowski, Todd V. Brennan, Robert J. Noveck, Janet S. Staats, Liwen Lin, Linda Stempora, Constance Hammond, Ann Wouters, Christopher F. Mojcik, John Cheng, Mark Collinge, Michael I. Jesson, Anasuya Hazra, Pinaki Biswas, Shuping Lan, James D. Clark, Jennifer A. Hodge, Reversibility of peripheral blood leukocyte phenotypic and functional changes after exposure to and withdrawal from tofacitinib, a Janus kinase inhibitor, in healthy volunteers. Clinical Immunology. ,vol. 191, pp. 10- 20 ,(2018) , 10.1016/J.CLIM.2018.03.002
Mathieu Uzzan, Minami Tokuyama, Adam K. Rosenstein, Costin Tomescu, Ivo N. SahBandar, Huaibin M. Ko, Louise Leyre, Anupa Chokola, Emma Kaplan-Lewis, Gabriela Rodriguez, Akihiro Seki, Michael J. Corley, Judith Aberg, Annalena La Porte, Eun-young Park, Hideki Ueno, Ioannis Oikonomou, Itai Doron, Iliyan D. Iliev, Benjamin K. Chen, Jennifer Lui, Timothy W. Schacker, Glaucia C. Furtado, Sergio A. Lira, Jean-Frederic Colombel, Amir Horowitz, Jean K. Lim, Nicolas Chomont, Adeeb H. Rahman, Luis J. Montaner, Lishomwa C. Ndhlovu, Saurabh Mehandru, Anti-α4β7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1–infected individuals Science Translational Medicine. ,vol. 10, ,(2018) , 10.1126/SCITRANSLMED.AAU4711
Shomron Ben-Horin, Gert Van Assche, Yehuda Chowers, Ella Fudim, Bella Ungar, Orit Picard, Miri Yavzori, Uri Kopylov, Ren Mao, Min-hu Chen, Yael Peled, Itai Gueta, Rami Eliakim, Ronen Loebstein, Noa Markovits, Pharmacokinetics and Immune Reconstitution Following Discontinuation of Thiopurine Analogues: Implications for Drug Withdrawal Strategies. Journal of Crohns & Colitis. ,vol. 12, pp. 1410- 1417 ,(2018) , 10.1093/ECCO-JCC/JJY122
Siew C Ng, Ida Normiha Hilmi, Aimee Blake, Fatima Bhayat, Shashi Adsul, Qasim Rana Khan, Deng-Chyang Wu, Low Frequency of Opportunistic Infections in Patients Receiving Vedolizumab in Clinical Trials and Post-Marketing Setting. Inflammatory Bowel Diseases. ,vol. 24, pp. 2431- 2441 ,(2018) , 10.1093/IBD/IZY153
Subrata Ghosh, Lianne S. Gensler, Zijiang Yang, Chris Gasink, Soumya D. Chakravarty, Kamyar Farahi, Paraneedharan Ramachandran, Elyssa Ott, Bruce E. Strober, Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn’s Disease: An Integrated Analysis of Phase II/III Clinical Development Programs Drug Safety. ,vol. 42, pp. 751- 768 ,(2019) , 10.1007/S40264-019-00797-3